Page last updated: 2024-11-08

delta(9-11)-tetrahydrocannabinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

delta(9-11)-tetrahydrocannabinol: RN given refers to (trans)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID167577
CHEMBL ID112253
SCHEMBL ID16781742
MeSH IDM0148793

Synonyms (27)

Synonym
delta 9-11 thc
PDSP2_000221
CHEMBL112253 ,
16849-44-8
(6ar,10ar)-6,6-dimethyl-9-methylidene-3-pentyl-7,8,10,10a-tetrahydro-6ah-benzo[c]chromen-1-ol
6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-, trans-(+-)-
delta(9-11)-tetrahydrocannabinol
delta-11-tetrahydrocannabinol
DTXSID20168570
(-)-.delta.9,11-thc
.delta.11-thc
.delta.11-tetrahydrocannabinol
6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-, (6ar,10ar)-
delta11-tetrahydrocannabinol
27179-28-8
unii-4d04v28wf1
4D04V28WF1 ,
delta11-thc
exo-tetrahydrocannabinol
6h-dibenzo(b,d)pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-, (6ar-trans)-
exo-tetrahydrocannabinol [usp-rs]
(-)-delta9,11-thc
SCHEMBL16781742
bdbm50229031
Q27259424
delta11-tetrahydrocannabinol (delta11-thc) 100 microg/ml in methanol
delta11-tetrahydrocannabinol (delta11-thc) 1000 microg/ml in methanol

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The legalization of cannabis in many parts of the United States and other countries has led to a need for a more comprehensive understanding of cannabis constituents and their potential for drug-drug interactions."( Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Lazarus, P; Nasrin, S; Perez-Paramo, YX; Watson, CJW, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Finally, a screening level risk assessment that combines the measured environmental concentrations (MECs) with dose-response data to estimate Hazard Quotients (HQs) for the compounds studied is also presented."( Drugs of abuse and benzodiazepines in the Madrid Region (Central Spain): seasonal variation in river waters, occurrence in tap water and potential environmental and human risk.
Barceló, D; González-Alonso, S; López de Alda, M; Mastroianni, N; Mendoza, A; Rodríguez-Gil, JL; Valcárcel, Y, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cannabinoid receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)0.33400.00020.660910.0000AID49003
Cannabinoid receptor 2Rattus norvegicus (Norway rat)IC50 (µMol)0.33400.00210.30900.8200AID49003
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID112374The compound was tested in vivo for locomotor activity in mice1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
AID112375The compound was tested in vivo for locomotor stimulus in rats1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
AID112372The compound was tested in vivo for hypothermic activity in mice1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
AID49003The compound was tested in vitro for binding activity against THC cannabinoid receptor site, using 3H-CP-55940 as the radioligand1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
AID112376The compound was tested in vivo for ring immobility in mice1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
AID116116The compound was tested in vivo for tail-flick latency in mice1991Journal of medicinal chemistry, Nov, Volume: 34, Issue:11
Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.56)18.7374
1990's5 (27.78)18.2507
2000's6 (33.33)29.6817
2010's4 (22.22)24.3611
2020's2 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]